Loading...

BioNexus Gene Lab Corp.

BGLC•NASDAQ
Healthcare
Medical - Diagnostics & Research
$4.90
$0.02(0.41%)

BioNexus Gene Lab Corp. (BGLC) Stock Chart & Performance Analysis

Explore BioNexus Gene Lab Corp.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
-2.26%
5-Day Change
-13.20%
1-Month Change
-40.55%
3-Month Change
563.61%
6-Month Change
417.90%
Year-to-Date (YTD) Change
443.86%
1-Year Change
236.43%
3-Year Change
-89.18%
5-Year Change
-91.78%
All-Time (Max) Change
-91.78%

Analyzing BioNexus Gene Lab Corp. (BGLC) Trends Across Multiple Time Frames

BioNexus Gene Lab Corp. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. BioNexus Gene Lab Corp. stock shows -2.26% 1-day change, indicating low volatility, while its 5-day change of -13.20% suggests a broader trend. Over a 1-month period, a -40.55% drop could signal a pullback, whereas a 3-month rise of 563.61% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of 417.90% and a YTD rise of 443.86% might concern investors, but a 1-year gain of 236.43% and a 3-year drop of -89.18% could indicate resilience. The 5-year surge of -91.78% highlights weak historical growth, while the all-time return of -91.78% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;